Peer-reviewedCC BY-NC-ND 4.0eBioMedicine
Targeting Pseudomonas aeruginosa ventilator-associated pneumonia with a non-antibiotic and biofilm-disrupting live biotherapeutic: preclinical safety and efficacy study
Related
- Phenotypic Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Patients With Ventilator-Associated Pneumonia: Insights Into Resistance Mechanisms and Biofilm Formation
- Antibiofilm and Quorum-sensing Agents Against Pseudomonas aeruginosa and Staphylococcus aureus: a Systematic Review of Preclinical Studies, 2022-2026
- Microbiological aetiology of paediatric ventilator-associated pneumonia and risk factors for carbapenem-resistant acinetobacter and Pseudomonas in a tertiary-care hospital in Thailand.
- SPA4 peptide attenuates the accumulation of selected damage-associated molecules and pulmonary cellularity during acute Pseudomonas aeruginosa infection in mice
- Antibiotic resistance patterns and associated genetic determinants among clinical isolates of Pseudomonas aeruginosa from a tertiary hospital in southern Iraq
BibTeX
@article{fernandezbarat2026targeting,
title = {{Targeting Pseudomonas aeruginosa ventilator-associated pneumonia with a non-antibiotic and biofilm-disrupting live biotherapeutic: preclinical safety and efficacy study}},
author = {Laia Fernández-Barat and Ana Motos and Carolina Segura-Morales and Kasra Kiarostami and Roberto Cabrera and Alba Soler-Comas and Alicia Broto and Rocco Mazzolini and Flavia Galli and Blanca Llonch and Guillem Macip and Nil Vazquez and Davide Calabretta and Marta Arrieta and Maria Lluch-Senar and Montserrat Rigol and Luis Serrano and Irene Rodríguez-Arce and Antoni Torres},
journal = {eBioMedicine},
year = {2026},
month = nov,
doi = {10.1016/j.ebiom.2026.106537},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2352396426004214},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Targeting Pseudomonas aeruginosa ventilator-associated pneumonia with a non-antibiotic and biofilm-disrupting live biotherapeutic: preclinical safety and efficacy study
AU - Laia Fernández-Barat
AU - Ana Motos
AU - Carolina Segura-Morales
AU - Kasra Kiarostami
AU - Roberto Cabrera
AU - Alba Soler-Comas
AU - Alicia Broto
AU - Rocco Mazzolini
AU - Flavia Galli
AU - Blanca Llonch
AU - Guillem Macip
AU - Nil Vazquez
AU - Davide Calabretta
AU - Marta Arrieta
AU - Maria Lluch-Senar
AU - Montserrat Rigol
AU - Luis Serrano
AU - Irene Rodríguez-Arce
AU - Antoni Torres
PY - 2026
DA - 2026/11/12
JO - eBioMedicine
DO - 10.1016/j.ebiom.2026.106537
UR - https://linkinghub.elsevier.com/retrieve/pii/S2352396426004214
SN - 2352-3964
ER -